Michael Webb, Epion Therapeutics - Innovators in Corneal Strengthening | LSI Europe '24

Epion Therapeutics is developing a minimally -invasive treatment for ectatic corneal disease that can bring early intervention to millions of patients globally.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Michael Webb
Michael Webb
CEO, Epion Therapeutics